申请人:Minnesota Mining and Manufacturing Company
公开号:US04411893A1
公开(公告)日:1983-10-25
Topical therapeutic compositions are disclosed which contain from about 0.1 to 70 percent by weight of a water-soluble tertiary amine oxide and a therapeutic agent selected from the group consisting of erythromycin, benzoyl peroxide, hydrocortisone, tetracycline, 5-fluorouracil, and propranolol. The amine oxide enhances penetration of the therapeutic agent into and through the skin.
揭示了含有约0.1至70重量%水溶性三级胺氧化物和从红霉素,过氧化苯甲酰,氢化可的松,四环素,5-氟尿嘧啶和普萘洛尔组成的治疗剂的局部治疗组合物。胺氧化物增强了治疗剂进入和穿透皮肤的能力。